Arbutus Biopharma Corporation (ABUS)

[MinnieM]

Form CT ORDER - Confidential treatment order filed 21sept15
http://www.sec.gov/Archives/edgar/data/1447028/999999999715013539/filename1.pdf

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
September 21, 2015
ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Arbutus Biopharma Corporation
File No. 1-34949 - CF#32803
_____________________
Arbutus Biopharma Corporation submitted an application under Rule 24b-2 requesting confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed August 7, 2015.
Based on representations by Arbutus Biopharma Corporation that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibits will not be released to the public for the time periods specified:

Exhibit 10.1 through August 5, 2025
Exhibit 10.2 through August 5, 2025
Exhibit 10.3 through August 5, 2025
Exhibit 10.4 through August 5, 2025
Exhibit 10.5 through August 5, 2025
For the Commission, by the Division of Corporation Finance, pursuant to delegated authority:
Brent J. Fields
Secretary

*****

The exhibits can still be found if anyone wants to grab them before they disappear.